Evidence map›Paper›PMID 36186297›Full record

ArticleFrontiers in psychology2022

Cross-cultural adaptation and initial validation of the Brazilian-Portuguese version of the pediatric automated neuropsychological assessment metrics.

Jaqueline Cristina de Amorim, Simone Thiemi Kishimoto, Cibele Longobardi Cutinhola Elorza, Flávia Alegretti Cavaletti, Roberto Marini, Clovis Artur Silva, Claudia Saad-Magalhães, Paula Teixeira Fernandes, Hermine I Brunner, Simone Appenzeller

Abstract read
In one paragraph

Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaqueline Cristina de AmorimPost-graduate Program of Child and Adolescent Health, School of Medical Science, University of Campinas, Campinas, Brazil.
Simone Thiemi KishimotoLaboratory of Autoimmune Diseases, School of Medical Science, University of Campinas, Campinas, Brazil.
Cibele Longobardi Cutinhola ElorzaPost-graduate Program of Child and Adolescent Health, School of Medical Science, University of Campinas, Campinas, Brazil.
Flávia Alegretti CavalettiLaboratory of Autoimmune Diseases, School of Medical Science, University of Campinas, Campinas, Brazil.
Roberto MariniLaboratory of Autoimmune Diseases, School of Medical Science, University of Campinas, Campinas, Brazil.
Clovis Artur SilvaChild and Adolescent Institute, Clinical Hospital (HCFMUSP), São Paulo of University, São Paulo, Brazil.
Claudia Saad-MagalhãesPediatric Rheumatology Division, Botucatu School of Medicine, São Paulo State University (UNESP), São Paulo, Brazil.
Paula Teixeira FernandesDepartment of Sport Sciences, Faculty of Physical Education, University of Campinas, Campinas, Brazil.
Hermine I BrunnerDivision of Rheumatology, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States.
Simone AppenzellerLaboratory of Autoimmune Diseases, School of Medical Science, University of Campinas, Campinas, Brazil.

Funding

Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)P30AR076316 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI BRUNNER, HERMINE I · 2019 to 2023
$3.4M
NIAMS NIH HHS P30 AR076316
6 · The paper itself

Abstract

Automated neuropsychiatric batteries have been used in research and clinical practice, including for chronic diseases, such as Systemic Lupus Erythematosus. The Pediatric Automated Neuropsychological Assessment Metrics battery (Ped-ANAM), originally developed for use in American-English speaking individuals, allows tracking of cognitive functions. It can be applied to people over 9 years old. The aim of this study was to translate and present initial validation data from the Ped-ANAM into Brazilian-Portuguese. We translated the battery according to Beaton's guidelines. Psychometric properties were tested, internal consistency was analyzed by Cronbach's alpha coefficient, test-retest reliability by the intraclass correlation coefficient (ICC). Further, we measured the test execution speed at both times as a temporal stability. Principal component analysis (PCA) was used for structural validity. Evidence of construct validity was assessed through assessment of the relationships with the Wechsler Intelligence Scales. All participants prior to the start of study related activities signed an informed consent form approved by the local ethics committee. A sample of 230 individuals [mean (range) of age: 23 (9 to 60) years; 65% females] was included; a subset of 51 individuals [mean (range) of age: 18 (9 to 57) years, 59% female] completed the Ped-ANAM twice to assess test-retest reliability, and another subset of 54 individuals [mean (range) of age: 20.4 (7 to 62) years; 67% female] completed the Wechsler Intelligence Scales for Children and Adult for assessment of the Ped-ANAM's construct validity. Our results suggest that the internal consistency of the Ped-ANAM (Cronbach's α = 0.890) and its subtest test-retest reliability were excellent (ICC: 0.59 to 0.94). There was no clustering in the Principal Components Analysis, suggestive of non-grouping of the evaluated variables. Construct validity assessment to the Wechsler Scales showed expected ranges of low to strong correlations (Spearman correlations: ρ = 0.40 to ρ = 0.69). We concluded that, based on the results of this study, a cross-culturally validated Brazilian-Portuguese version of the Ped-ANAM has been developed and it is a reliable tool for the screening cognitive function.

Indexed as

Brazilian-PortuguesecognitionPed-ANAMpsychologytranslationvalidation

Identifiers

PMID36186297
PMCPMC9524254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.